Skip to main content
. 2021 Apr 16;36(7):1808–1820. doi: 10.1093/humrep/deab089

Table III.

Serum 25(OH)D concentrations and risk of moderate/severe psychological premenstrual symptoms during the premenstrual week in two cohorts of reproductive age women with regular cycles: EAGeR and BioCycle.

EAGeR
BioCycle
25(OH)D sufficient (≥ 30 ng/ml) 25(OH)D insufficient (< 30 ng/ml) 25(OH)D (per 10 ng/ml) 25(OH)D sufficient (≥ 30 ng/ml) 25(OH)D insufficient (< 30 ng/ml) 25(OH)D (per 10 ng/ml)
Total number of moderate/severe psychological symptoms
Mean ± SD 1.2 ± 1.5 1.2 ± 1.5 0.7 ± 1.1 1.2 ± 1.3
Unadjusted β (95% CI) Ref 0.07 (0.11, 0.25) 0.01 (0.08, 0.06) Ref 0.40 (0.19, 0.98) 0.23 (0.57, 0.10)
Adjusted 1: β (95% CI) Ref 0.02 (0.17, 0.21) 0.01 (0.07, 0.09) Ref 0.34 (0.25, 0.93) 0.24 (0.59, 0.11)
Adjusted 2: β (95% CI) Ref 0.03 (0.16, 0.22) 0.02 (0.06, 0.10) Ref 0.26 (0.27, 0.80) 0.22 (0.53, 0.09)
Depression or sadness
Prevalence 91 (16.8) 107 (17.9) 3 (8.8) 5 (12.8)
Unadjusted RR (95% CI) Ref 1.06 (0.83, 1.37) 1.01 (0.92, 1.12) Ref 1.45 (0.37, 5.77) 0.58 (0.25, 1.35)
Adjusted 1: RR (95% CI) Ref 1.07 (0.82, 1.40) 0.99 (0.90, 1.12) Ref 1.34 (0.29, 6.16) 0.45 (0.12, 1.63)
Adjusted 2: RR (95% CI) Ref 1.10 (0.84, 1.44) 1.00 (0.89, 1.12) Ref 1.42 (0.10, 19.7) 0.63 (0.11, 3.67)
Tension or irritability
Prevalence 215 (39.8) 246 (41.3) 8 (23.5) 13 (33.3)
Unadjusted RR (95% CI) Ref 1.04 (0.90, 1.20) 0.99 (0.93, 1.05) Ref 1.42 (0.66, 3.04) 0.81 (0.53, 1.24)
Adjusted 1: RR (95% CI) Ref 1.00 (0.86, 1.16) 1.00 (0.94, 1.07) Ref 1.41 (0.61, 3.29) 0.68 (0.39, 1.20)
Adjusted 2: RR (95% CI) Ref 0.98 (0.84, 1.14) 1.02 (0.95, 1.09) Ref 1.64 (0.58, 4.66) 0.59 (0.28, 1.23)
Anxiety or nervousness
Prevalence 97 (17.9) 116 (19.4) 5 (14.7) 10 (25.6)
Unadjusted RR (95% CI) Ref 1.09 (0.85, 1.38) 1.03 (0.93, 1.14) Ref 1.74 (0.65, 4.68) 0.73 (0.42, 1.28)
Adjusted 1: RR (95% CI) Ref 1.06 (0.82, 1.36) 1.04 (0.94, 1.16) Ref 2.93 (0.79, 10.79) 0.50 (0.19, 1.30)
Adjusted 2: RR (95% CI) Ref 1.04 (0.80, 1.34) 1.06 (0.95, 1.19) Ref 2.14 (0.22, 20.85) 0.56 (0.14, 2.26)
Anger, aggression, short temper
Prevalence 154 (28.5) 171 (28.6) 6 (18.2) 12 (30.8)
Unadjusted RR (95% CI) Ref 1.00 (0.84, 1.21) 0.96 (0.89, 1.04) Ref 1.69 (0.70, 4.07) 0.70 (0.43, 1.16)
Adjusted RR (95% CI) Ref 0.93 (0.77, 1.13) 1.00 (0.92, 1.08) Ref 2.19 (0.78, 6.13) 0.64 (0.33, 1.24)
Adjusted 2: RR (95% CI) Ref 0.92 (0.76, 1.13) 1.01 (0.92, 1.10) Ref 1.18 (0.22, 6.19) 0.84 (0.30, 2.39)
Crying spells
Prevalence 75 (13.9) 100 (16.8) 2 (5.9) 3 (7.7)
Unadjusted RR (95% CI) Ref 1.21 (0.92, 1.60) 0.96 (0.85, 1.09) Ref 1.31 (0.23, 7.59) 1.43 (0.58, 3.53)
Adjusted 1: RR (95% CI) Ref 1.11 (0.83, 1.48) 1.00 (0.88, 1.13) Ref 2.01 (0.18, 22.43) 1.18 (0.25, 5.50)
Adjusted 2: RR (95% CI) Ref 1.24 (0.92, 1.68) 0.98 (0.86, 1.12) Ref 0.94 (0.08, 11.57) 1.31 (0.24, 7.08)

25(OH)D, 25-hydroxyvitamin D; EAGeR, Effects of Aspirin in Gestation and Reproduction; Ref, Reference; RR, risk ratio.

Bold results are significant at α = 0.05.

*

Indicates comparisons that remained after adjustment for false discovery rate.

Adjusted 1 model controls for age, BMI, smoking status, race, income, exercise, and season of blood draw.

Adjusted 2 model controls for the variables in Adjusted 1 as well as depression (BioCycle) or antidepressant use (EAGeR), education, alcohol, race (EAGeR only), CRP (high sensitivity c-reactive protein), and parity.